I would like to acknowledge the traditional owners of the lands on which this guideline was developed. I pay my respects to elders, past, present and emerging. I also acknowledge those in Australia living with attention deficit hyperactivity disorder (ADHD). I hope that the language used throughout this guideline respects and honours your lived experience of ADHD.
The Australian ADHD Professionals Association (AADPA) was formed in 2016 when a group of professionals came together, motivated by a desire to see a ’better deal’ for the around 1 million Australians living with ADHD. The AADPA membership is interdisciplinary, with members having backgrounds including, but not limited to, psychiatry, paediatrics, psychology, allied health and ADHD coaching, as well as research into the causes and treatments of ADHD.
AADPA was extremely fortunate to obtain funding from the Australian Government Department of Health (Grant Agreement ID: 4-A168GGT) in 2018 to deliver the Support for People Impacted by ADHD Program. A key piece of early work conducted by AADPA under this grant was the commissioning of Deloitte Access Economics to fully evaluate the social and economic costs of ADHD in Australia.
This evaluation estimated that ADHD costs $20.42 billion per year, or $25,071 per individual with ADHD per annum (Sciberras et al., 2022). A further key objective of this grant – and indeed a key motivation for the establishment of AADPA – was the formulation of an Australian evidence-based clinical practice guideline for ADHD. Accordingly, on 14 August 2019, AADPA registered its intent with Australia’s National Health and Medical Research Council (NHMRC) to develop a clinical practice guideline (NHMRC Guideline ID: 273) for ADHD.
Since that time, AADPA has engaged widely with the Australian professional and consumer communities to ensure the formulation of a guideline that is evidence-based, acknowledges that caring for individuals with ADHD requires an interdisciplinary approach, and respects the voices of those with a lived experience of ADHD.